Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review.

Lingaratnam S, Hussainy SY, Murphy A, Perrin C, Samuvel M, Mehrvarz E, Lim CX, Zalcberg J

Open source

DOI: 10.1080/20523211.2024.2389120
Published: 2024
Container: Journal of pharmaceutical policy and practice
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/20523211.2024.2389120,
  title = {Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review.},
  author = {Lingaratnam S and Hussainy SY and Murphy A and Perrin C and Samuvel M and Mehrvarz E and Lim CX and Zalcberg J},
  year = {2024},
  journal = {Journal of pharmaceutical policy and practice},
  doi = {10.1080/20523211.2024.2389120},
  url = {https://doi.org/10.1080/20523211.2024.2389120}
}

RIS

TY  - JOUR
TI  - Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review.
AU  - Lingaratnam S
AU  - Hussainy SY
AU  - Murphy A
AU  - Perrin C
AU  - Samuvel M
AU  - Mehrvarz E
AU  - Lim CX
AU  - Zalcberg J
PY  - 2024
JO  - Journal of pharmaceutical policy and practice
DO  - 10.1080/20523211.2024.2389120
UR  - https://doi.org/10.1080/20523211.2024.2389120
ER  -

APA

S, L., SY, H., A, M., C, P., M, S., E, M., CX, L., & J, Z. (2024). Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review.. Journal of pharmaceutical policy and practice. https://doi.org/10.1080/20523211.2024.2389120

Source records

pubmed · retrieved 2026-09-26T22:59:08.162Z
europe-pmc · retrieved 2026-09-26T22:59:08.178Z
doaj · retrieved 2026-09-26T22:59:08.189Z